^
Association details:
Biomarker:ROR1 positive
Cancer:Lung Cancer
Drug:NKTR-255 (IL-15R agonist)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Source:
Title:

1152 - NKTR-255, a polymer-conjugated IL-15, dramatically improves ROR1 CAR-T cell persistence and anti-tumor efficacy in an autochthonous model of ROR1+ lung cancer

Published date:
03/15/2023
Excerpt:
Together, our work shows that NKTR-255 dramatically improves the persistence, function, and anti-tumor activity of ROR1 CAR-T cells in an aggressive autochthonous model of ROR1+ lung cancer.
Secondary therapy:
T-lymphocyte cell therapy